Insilico Medicine and Collaborator Discover Novel Alzheimer’s Disease Targets Through AI and Rigorous Experimental Validation - Insilico Medicine

Researchers used AI to identify promising new drug targets for Alzheimer's disease and then validated them through laboratory testing. This could eventually lead to better treatments for a disease affecting millions of people.